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Mice and humans with growth hormone receptor/
IGF-1 deficiencies display major reductions in age-
related diseases. Because protein restriction re-
duces GHR-IGF-1 activity, we examined links
between protein intake and mortality. Respondents
aged 50–65 reporting high protein intake had a 75%
increase in overall mortality and a 4-fold increase in
cancer death risk during the following 18 years.
These associations were either abolished or attenu-
ated if the proteins were plant derived. Conversely,
high protein intake was associated with reduced
cancer and overall mortality in respondents over 65,
but a 5-fold increase in diabetes mortality across all
ages. Mouse studies confirmed the effect of high
protein intake and GHR-IGF-1 signaling on the inci-
dence and progression of breast and melanoma
tumors, but also the detrimental effects of a low pro-
tein diet in the very old. These results suggest that
low protein intake during middle age followed by
moderate to high protein consumption in old adults
may optimize healthspan and longevity.
INTRODUCTION
Caloric restriction (CR) without malnutrition has been consis-
tently shown to increase longevity in a number of animal
models, including yeast, C. elegans, and mice (Fontana et al.,
2010). However, the effect of CR on the lifespan of nonhuman
primates remains controversial and may be heavily influenced
by dietary composition (Cava and Fontana, 2013; ColmanCeet al., 2009; Fontana and Klein, 2007; Mattison et al., 2012;
Mercken et al., 2013; Stein et al., 2012). The lifespan extension
associated with CR in model organisms is believed to operate
through its effects on growth hormone (GH) and GH receptor
(GHR), leading to subsequent deficiencies in IGF-1 and insulin
levels and signaling (Bartke et al., 2001; Bellush et al., 2000;
Fontana et al., 2010; Hauck et al., 2002; Wei et al., 2009). The
effect of the insulin/IGF-1 pathway on longevity was first
described in C. elegans by showing that mutations in the insu-
lin/IGF-1 receptor or in the downstream age-1 gene caused a
several-fold increase in lifespan (Johnson, 1990; Kenyon et al.,
1993, Kenyon, 2010). Other studies revealed that mutations
in orthologs of genes functioning in insulin/IGF-1 signaling, but
also activated independently of insulin/IGF-1, including TOR-
S6K and RAS-cAMP-PKA, promoted aging in multiple model or-
ganisms, thus providing evidence for the conserved regulation
of aging by pro-growth nutrient signaling pathways (Fabrizio
et al., 2001; Guarente and Kenyon, 2000; Kapahi and Zid,
2004; Kenyon, 2005, 2011; Longo, 1999; Tatar et al., 2001).
Not surprisingly, in mice, growth hormone receptor deficiency
(GHRD) or growth hormone deficiency (GHD), both of which
display low levels of IGF-1 and insulin, cause the strongest life-
span extension but also reduction of age-related pathologies
including cancer and insulin resistance/diabetes (Brown-Borg
and Bartke, 2012; Brown-Borg et al., 1996; Masternak and
Bartke, 2012).
Recently, we showed that humans with growth hor-
mone receptor deficiency (GHRD), also exhibiting major defi-
ciencies in serum IGF-1 and insulin levels, displayed no cancer
mortality or diabetes. Despite having a higher prevalence of
obesity, combined deaths from cardiac disease and stroke in
this group were similar to those in their relatives (Guevara-
Aguirre et al., 2011). Similar protection from cancer was also
reported in a study that surveyed 230 GHRDs (Steuerman
et al., 2011).ll Metabolism 19, 407–417, March 4, 2014 ª2014 Elsevier Inc. 407
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Protein Intake, IGF-1, and MortalityProtein restriction or restriction of particular amino acids,
such as methionine and tryptophan, may explain part of the
effects of calorie restriction and GHRD mutations on longevity
and disease risk, since protein restriction is sufficient to reduce
IGF-1 levels and can reduce cancer incidence or increase
longevity in model organisms, independently of calorie intake
(Ayala et al., 2007; Fontana et al., 2008, 2013; Gallinetti et al.,
2013; Hora´kova´ et al., 1988; Hursting et al., 2007; Leto
et al., 1976; Mair et al., 2005; Pamplona and Barja, 2006; Peng
et al., 2012; Ross, 1961; Sanz et al., 2006; Smith et al., 1995;
Youngman, 1993).
Here, we combined an epidemiological study of 6,381 USmen
and women aged 50 and above from NHANES III, the only
nationally representative dietary survey in the United States,
with mouse and cellular studies to understand the link between
the level and source of proteins and amino acids, aging, dis-
eases, and mortality.
RESULTS
Human Population
The study population included 6,381 adults ages 50 and over
from NHANES III, a nationally representative, cross-sectional
study. Our analytic sample had a mean age of 65 years and is
representative of the United States population in ethnicity, edu-
cation, and health characteristics (Table S1).
On average, subjects consumed 1,823 calories, of which the
majority came from carbohydrates (51%), followed by fat
(33%) and protein (16%), with most of it (11%) derived from an-
imal protein. The percent of calorie intake from protein was used
to categorize subjects into a high protein group (20% or more
of calories from proteins), a moderate protein group (10%–
19% of calories from proteins), and a low protein group (less
than 10% of calories from proteins).
Mortality follow-up was available for all NHANES III partici-
pants through linkage with the National Death Index up until
2006 (DHHS, 2001). This provided the timing and cause of death.
The follow-up period for mortality covered 83,308 total person-
years over 18 years, with 40% overall mortality, 19% cardiovas-
cular disease (CVD) mortality, 10% cancer mortality, and about
1% diabetes mortality.
Association between Protein and Mortality
Using Cox Proportional Hazard models, we found that high and
moderate protein consumption were positively associated with
diabetes-related mortality, but not associated with all-cause,
CVD, or cancer mortality when subjects at all the ages above
50 were considered. Results showed that both the moderate
and high protein intake groups had higher risks of diabetes mor-
tality compared to participants in the low protein group. Although
taken together these results indicate that moderate to high pro-
tein intake promotes diabetes mortality, larger studies are
necessary to test this possibility further. An alternative explana-
tion for the elevated diabetes mortality in the higher protein
group is that, following a diabetes diagnosis, some individuals
may switch to a diet comprised of higher protein, lower fat,
and low carbohydrates. To test this, we examined the associa-
tion between protein intake and diabetesmortality in participants
who had no prevalence of diabetes at baseline (Table S7).408 Cell Metabolism 19, 407–417, March 4, 2014 ª2014 Elsevier Inc.Among subjects with no diabetes at baseline, those in the high
protein group had a 73-fold increase in risk (HR: 73.52; 95% CI:
4.47–1,209.70), while those in the moderate protein category
had an almost 23-fold increase in the risk of diabetes mortality
(HR: 22.93; 95% CI: 1.31–400.70). We underline that our hazard
ratios and confidence intervalsmay be inflated due to our sample
size and the extremely low incidence of diabetes mortality in the
low protein group. Overall, there were only 21 diabetes deaths
among persons without diabetes at baseline, only 1 of which
was from the low protein group. Nevertheless, despite the small
sample size, our results still show significant associations be-
tween increased protein intake and diabetes-related mortality.
To determine whether the association between protein and
mortality differed for middle-aged and older adults, Cox propor-
tional hazard models were rerun, testing for an interaction be-
tween protein consumption and age. Significant interactions
were found for both all-cause and cancer mortality, indicating
that the low protein diet was beneficial in mid-life; however, its
benefits declined with age (Figure 1). Based on these results,
we stratified the population into two age groups, those ages 50–
65 (n = 3,039) and those ages 66+ (n = 3,342), and re-examined
relationships between protein and cause-specific mortality.
Among those ages 50–65, higher protein levels were linked to
significantly increased risks of all-cause and cancer mortality
(Table 1). In this age range, subjects in the high protein group
had a 74% increase in their relative risk of all-cause mortality
(HR: 1.74; 95% CI: 1.02–2.97) and were more than four times as
likely to die of cancer (HR: 4.33; 95% CI: 1.96–9.56) when
compared to those in the low protein group. None of these asso-
ciations was significantly affected by controlling for percent
calories from total fat or for percent calories from total carbohy-
drates. However, when the percent calories from animal protein
was controlled for, the association between total protein and all-
cause or cancermortalitywas eliminated or significantly reduced,
respectively, suggesting animal proteins are responsible for a sig-
nificant portion of these relationships. Whenwe controlled for the
effect of plant-based protein, there was no change in the associ-
ation between protein intake and mortality, indicating that high
levels of animal proteins promote mortality and not that plant-
based proteins have a protective effect (Table S5).
Compared to subjects reporting a low protein diet, subjects
who consumed moderate levels of protein also had a 3-fold
higher cancer mortality (HR: 3.06; 95% CI: 1.49–6.25), which
was not accounted for by either percent calories from fat
or percent calories from carbohydrates, but was marginally
reduced when controlling for percent calories from animal pro-
tein (HR: 2.71; 95%CI: 1.24–5.91), although the size of the effect
was not as large as for those in the high protein group. Taken
together, these results indicate that respondents ages 50–65
consuming moderate to high levels of animal protein display a
major increase in the risks for overall and cancer mortality; how-
ever, the risks may be somewhat decreased if protein does not
come from an animal source. Similar results were obtained if
the population 45–65 was considered, although few deaths
occurred in the 45–50 group (data not shown).
In contrast to the findings above, among respondents who
were 66 years of age and over at baseline, higher protein levels
were associated with the opposite outcomes for overall and can-
cer mortality but a similar outcome for diabetes mortality
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Figure 1. Association between Protein
Intake and Mortality
Using Cox proportional hazard models, statisti-
cally significant (p < 0.05) interactions between
age and protein group were found for all-cause
and cancer mortality. Based on these models,
predicted remaining life expectancy was calcu-
lated for each protein group by age at baseline.
Overall, low protein appears to have a protective
effect against all-cause and cancer mortality prior
to age 66, at which point it becomes detrimental.
No significant interactions were found for cardio-
vascular disease (CVD) and diabetes mortality.
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Protein Intake, IGF-1, and Mortality(Table 1). When compared to those with low protein consump-
tion, subjects who consumed high amounts of protein had a
28% reduction in all-cause mortality (HR: 0.72; 95% CI: 0.55–
0.94), while subjects who consumed moderate amounts of pro-
tein displayed a 21% reduction in all-cause mortality (HR: 0.78;
95% CI: 0.62–0.99). Furthermore, this was not affected by
percent calories from fat, from carbohydrates, or from animal
protein. Subjects with high protein consumption also had a
60% reduction in cancer mortality (HR: 0.40; 95% CI: 0.23–
0.71) compared to those with low protein diets, which was also
not affected when controlling for other nutrient intake or protein
source.
The Influence of IGF-1 on the Association between
Protein and Mortality
Adjusted mean IGF-1 levels were positively associated with pro-
tein consumption for both age groups (Figure 2). Because IGF-1
was only available for a randomly selected subsample (n =
2,253), we re-examined the age-specific associations between
protein and cause-specific mortality in this sample and found
them to be similar to what was seen in the full sample, although
with somewhat larger effect sizes (Table S3). Next we examined
whether IGF-1 acted as a moderator or mediator in the associa-
tion between protein and mortality. We found that while IGF-1
did not account for the association between protein consump-
tion and mortality (Table S3), it was an important moderator of
the association, as indicated by the statistically significant inter-
actions between protein and IGF-1 level (Table S4).
From these models, predicted hazard ratios by IGF-1 and pro-
tein group were calculated (Figure S2). Results showed that for
every 10 ng/ml increase in IGF-1, the mortality risk of cancer
among subjects ages 50–65 increases for the high protein versus
the low protein group by an additional 9% (HRhigh protein x IGF-1:
1.09; 95% CI: 1.01–1.17). In contrast, among older subjectsCell Metabolism 19, 407–4(66+ years), when comparing those in
the low protein group, subjects with high
or moderate protein diets had a reduced
risk of CVD mortality if IGF-1 was also
low; however, no benefits were found
with increased IGF-1.
Protein Intake, IGF-1, and Cancer
in Mice
To verify causation and understand the
mechanism that may link proteins to can-cer and overall mortality, we studied the effect of a range of pro-
tein intake (4%–18%) similar to that of subjects in the NHANES III
study on the levels of circulating IGF-1, cancer incidence, and
cancer progression in mice. Eighteen-week-old male C57BL/6
mice were fed continuously for 39 days with experimental, isoca-
loric diets designed to provide either a high (18%) or a low (4%–
7%) amount of calories derived from protein, without imposing
CR or causing malnutrition (Figures S1A and S1B).
To understand how the different levels of protein and IGF-1
may affect the ability of a newly formed tumor to survive and
grow after 1 week on diets containing different protein levels,
both groups were implanted subcutaneously with 20,000 synge-
neic murine melanoma cells (B16). Tumor measurements began
15 days postimplantation and after 22 days on the diets, at which
point incidence was found to be 100% for the high protein level
(18%) group but 80% for the low protein level (4%) group (Fig-
ure 3A). At day 25, incidence rose to 90% in the low protein group
and remained there until the end of the experiment (Figure 3A).
From day 22 until the end of the experiment, tumor size was
significantly smaller in the group consuming a lower amount of
proteins, indicating a much slower tumor progression. At day
39 the mean tumor size was 78% larger in the high compared
to the low protein group (day 36, p = 0.0001; day 39, p <
0.0001) (Figure 3B). To test the hypothesis that GHR signaling
may be involved in this effect of protein levels, blood samples
were obtained and analyzed at day 16 to determine the levels
of IGF-1 and the IGF-1 inhibitory protein IGFBP-1 (Wolpin
et al., 2007). Serum IGF-1 was 35% lower (p = 0.0004) in the
low protein group when compared to animals fed the high pro-
tein diet (Figure 3C). Conversely, serum IGFBP-1 was 136%
higher (p = 0.003) in the low protein group compared to the
high protein group (Figure 3D).
To test further the hypothesis that the GHR-IGF-1 axis
promotes cancer progression, we implanted subcutaneous17, March 4, 2014 ª2014 Elsevier Inc. 409
Table 1. Associations between Mortality and Protein Intake
Hazard Ratio (95% CI)
Ages 50–65 (N = 3,039) Ages 66+ (N = 3,342)
Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4
All-Cause Mortality
Moderate protein (n = 4,798) 1.34 (0.81–2.22) 1.37 (0.82–2.27) 1.35 (0.80–2.29) 1.15 (0.67–1.96) 0.79 (0.62–0.99) 0.79 (0.62–0.99) 0.79 (0.62–0.99) 0.79 (0.61–1.01)
High protein (n = 1,146) 1.74 (1.02–2.97) 1.77 (1.03–3.03) 1.74 (0.99–3.05) 1.18 (0.60–2.31) 0.72 (0.55–0.94) 0.73 (0.56–0.95) 0.72 (0.55–0.94) 0.72 (0.50–1.02)
% kcal fat – 0.99 (0.98–1.01) – – – 1.00 (0.99–1.01) – –
% kcal carbs – – 1.00 (0.99–1.01) – – – 1.00 (0.99–1.00) –
% kcal animal protein – – – 1.03 (1.00–1.06) – – – 1.00 (0.98–1.02)
CVD Mortality
Moderate protein (n = 4,798) 0.79 (0.40–1.54) 0.83 (0.43–1.60) 0.81 (0.41–1.62) 0.61 (0.29–1.29) 0.80 (0.57–1.12) 0.80 (0.57–1.12) 0.80 (0.57–1.12) 0.80 (0.56–1.14)
High protein (n = 1,146) 1.03 (0.51–2.09) 1.08 (0.54–2.15) 1.10 (0.52–2.31) 0.55 (0.19–1.62) 0.78 (0.54–1.14) 0.79 (0.54–1.15) 0.78 (0.53–1.15) 0.77 (0.48–1.25)
% kcal fat – 0.99 (0.97–1.01) – – – 1.00 (0.99–1.01) – –
% kcal carbs – – 1.00 (0.99–1.02) – – – 1.00 (0.99–1.01) –
% kcal animal protein – – – 1.04 (0.99–1.11) – – – 1.00 (0.98–1.02)
Cancer Mortality
Moderate protein (n = 4,798) 3.06 (1.49–6.25) 3.13 (1.52–6.44) 3.56 (1.65–7.65) 2.71 (1.24–5.91) 0.67 (0.43–1.06) 0.67 (0.43–1.06) 0.67 (0.42–1.05) 0.66 (0.40–1.07)
High protein (n = 1,146) 4.33 (1.96–9.56) 4.42 (2.01–9.74) 4.98 (2.13–11.66) 3.19 (1.21–8.35) 0.40 (0.23–0.71) 0.41 (0.23–0.73) 0.39 (0.22–0.69) 0.38 (0.17–0.82)
% kcal fat – 0.99 (0.98–1.01) – – – 1.02 (1.01–1.03) – –
% kcal carbs – – 1.00 (0.98–1.01) – – – 1.00 (0.99–1.01) –
% kcal animal protein – – – 1.02 (0.97–1.07) – – – 1.00 (0.97–1.04)
Diabetes Mortality
Moderate protein (n = 4,798) 3.43 (0.69–17.02) 3.36 (0.67–16.96) 3.41 (0.67–17.36) 2.99 (0.58–15.31) 5.38 (0.95–30.49) 5.05 (0.93–27.34) 4.93 (0.89–27.35) 6.20 (0.35–37.01)
High protein (n = 1,146) 3.93 (0.73–21.07) 3.88 (0.71–21.17) 3.90 (0.67–22.84) 2.77 (0.24–31.73) 10.64 (1.85–61.31) 10.42 (1.88–57.87) 9.07 (1.49–55.30) 15.16 (1.93–118.9)
% kcal fat – 1.01 (0.97–1.05) – – – – – –
% kcal carbs – – 1.00 (0.96–1.04) – – – – –
% kcal animal protein – – – 1.02 (0.92–1.14) – – – –
Reference = low protein (n = 437 in both age groups). Model 1 (baseline model): Adjusted for age, sex, race/ethnicity, education, waist circumference, smoking, chronic conditions (diabetes, cancer,
myocardial infarction), trying to lose weight in the last year, diet changed in the last year, reported intake representative of typical diet, and total calories. Model 2: Adjusted for covariates and% kcals
from total fat. Model 3: Adjusted for covariates and % kcals from total carbohydrates. Model 4: Adjusted for covariates and % kcals from animal protein.
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Figure 2. Serum IGF-1 Levels in Respondents 50–65 and 66+ Report-
ing Low, Moderate, or High Protein Intake
IGF-1 in respondents ages 50–65 is significantly lower among those with low
protein intake when compared to high (p = 0.004). For those ages 66+ the
difference between high and low intake becomes marginally significant (p =
0.101). The cohort for which IGF-1 levels were calculated includes 2,253
subjects. Of those ages 50–65 (n = 1,125), 89 were in the low protein category,
854 were in the moderate protein category, and 182 were in the high protein
category. Of those ages 66+ (n = 1,128), 80 were in the low protein category,
867 were in the moderate protein category, and 181 were in the high protein
category. Data points represent the mean ± SEM. *p < 0.01.
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Protein Intake, IGF-1, and Mortalitymelanoma (B16) into GHR/IGF-1-deficient GHRKO mice and
their respective age- and sex-matched littermate controls (18-
week-old male C57BL/6 mice). Tumor measurements began
10 days postimplantation and continued until day 18. The data
show that tumor progression is strongly inhibited in the GHRKO
mice when compared to progression in the control group (Fig-
ures 3E and S1L; p < 0.01).
We also tested the effect of protein intake on breast cancer
incidence and progression in a mouse model. Twelve-week-old
femaleBALB/cmicewereplacedunder the samedietary regimen
as described for C57BL/6 mice, except that the mice had to be
switched from a 4% to a 7% kcal from protein diet within the first
week in order to prevent weight loss (Figures S1E and S1F). After
a week of feeding on these diets, mice were implanted subcuta-
neously with 20,000 cells of syngeneic, murine breast cancer
(4T1), and 15 days later animals were assessed for tumors. On
day 18 postimplantation (day 25 on the diet), tumor incidence
was 100% in the high protein (18%) group but only 70% in the
low protein (7%) group. The incidence in the low protein group
rose to 80% at day 39, where it remained until the end of the
experiment (Figure 3F). A 45% smaller mean tumor size was
also observed in the low protein group compared to the high pro-
tein group at the end of the experiment at day 53 (p = 0.0038) (Fig-
ure 3G). As for C57BL/6mice, IGF-1 wasmeasured after 16 days
from the switch to different protein levels. In the lowprotein intake
group, IGF-1 levels were reduced by 30% compared to those in
the high level group (p < 0.0001) (Figure 3H). Additionally, a low
protein intake also caused an IGFBP-1 increase of 84% (p =
0.001) (Figure 3I), similar to what was observed in the C57BL/6
genetic background (Figure 3D). Analogously, when soy protein
intake was reduced from high levels to low levels, we observed
a 30% decrease in IGF-1 (p < 0.0001) (Figure 3J) and a 140% in-Cecrease in IGFBP-1 (p < 0.0001) (Figure 3K). Although there was a
trend for an effect of substituting the same level of animal protein
with plant protein on IGF-1and IGFBP-1, thedifferenceswere not
significant. Thesedata suggest that lower protein intakemayplay
a role in decreasing cancer incidence and/or progression in part
by decreasing IGF-1 and increasing the IGF-1 inhibitor IGFBP-1.
Additional studies on various typesof animal- versusplant-based
proteins are necessary to determine their effect on cancer, IGF-1,
and IGFBP-1.
Cellular Studies
To test the hypothesis that there is a fundamental link between
the level of amino acids and lifespan, the impact of the presence
of specific concentrations of amino acids on yeast survival and
mutation rate was assayed. A wild-type DBY746 S. cerevisiae
strain was grown in the presence of half (0.53), standard (13),
and double (23) amino acid concentrations with all other nutri-
ents maintained constant. Survival was measured at days 1, 3,
5, and 8. No survival differences were observed during days 1
and 3. At day 5, the two highest amino acid concentrations
showed a trend for increased mortality, which resulted in a 10-
fold decrease in surviving cells by day 8 (Figure 3L).
In order to assess the relationship between amino acids,
aging, and age-dependent DNA damage, we used aging
S. cerevisiae to measure spontaneous mutation rate (Madia
et al., 2007). The mutation rate was 3- and 4-fold higher in
5-day-old but not young cells exposed to 13 and 23 amino
acid levels, respectively, compared to cells exposed to a 0.53
amino acid concentration (Figure 3M). These results indicate
that even in unicellular organisms, amino acids can promote
cellular aging and age-dependent genomic instability.
To further discern the pathways involved in promoting age-
dependent genomic instability, we measured the induction of
stress responsive genes regulated by the Ras-PKA-Msn2/4
and Tor-Sch9-Gis1 pathways in the presence or absence of
amino acids. For cells grown in control media containing only
tryptophan (Trp), leucine (Leu), and histidine (His) (essential for
growth in this strain), the presence of all amino acids in themedia
reduced the induction of stress resistance transcription factors
Msn2/4 (STRE) and Gis1 (PDS), indicating that the addition
of amino acids was sufficient to inhibit cellular protection
(Figure 3N).
The Tor-Sch9 pathway extends longevity but also promotes
DNA mutations (Madia et al., 2009; Wei et al., 2008). To
determine whether Ras-cAMP-PKA signaling also regulates
age-dependent genomic instability, we studied Ras2-deficient
mutants. We confirmed that ras2D mutants are long-lived (Fig-
ure S1H) but also show that inactivation of Ras signaling attenu-
ated age- and oxidative stress-dependent genomic instability
(Figures S1I, S1J, 3O, and S1K). Together, these results indicate
a mechanism where amino acids are able to affect mutation fre-
quency and thus genomic instability, at least in part, by activation
of the Tor-Sch9 and Ras/PKA pathways and decreased stress
resistance (Figure 3P).
Low Protein Intake andWeight Maintenance in Old Mice
Based on the observed opposite effects of a low protein diet in
subjects 50–65 years old versus those 66 and older and on
the major drop in BMI and IGF-1 levels after age 65, well Metabolism 19, 407–417, March 4, 2014 ª2014 Elsevier Inc. 411
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Figure 3. Effects of Proteins and Amino Acids on Tumor Progression or DNA Damage in Mouse and S. cerevisiae Models
(A) Tumor incidence in 18-week-old male C57BL/6 mice implanted with 20,000 melanoma (B16) cells and fed either a high protein (18%; n = 10) or low protein
(4%; n = 10) diet.
(B) B16 tumor volume progression in 18-week-old male C57BL/6 mice fed either a high protein (n = 10) or low protein (n = 10) diet.
(C) IGF-1 at day 16 in 18-week-old male C57BL/6 mice fed either a high protein (n = 5) or low protein (n = 5) diet.
(D) IGFBP-1 at day 16 in 18-week-old male C57BL/6 mice fed either a high protein (n = 10) or low protein (n = 10) diet.
(E) B16 melanoma tumor progression in 10-month-old female GHRKO mice (n = 5) versus age-matched littermate controls (Ctrl; n = 7).
(F) Tumor incidence in 12-week-old female BALB/c mice implanted with 20,000 breast cancer (4T1) cells and fed either a high protein (18%; n = 10) or low protein
(7%; n = 10) diet.
(G) 4T1 breast cancer progression in 12-week-old female BALB/c mice fed either a high protein (n = 10) or low protein (n = 10) diet.
(H) IGF-1 at day 16 in 12-week-old female BALB/c mice fed either a high animal protein (n = 5) or low animal protein (n = 5) diet.
(I) IGFBP-1 at day 16 in 12-week-old female BALB/c mice fed either a high animal protein (n = 10) or low animal protein (n = 10) diet.
(J) IGF-1 at day 16 in 12-week-old female BALB/c mice fed either a high soy protein (n = 5) or low soy protein (n = 5) diet.
(K) IGFBP-1 at day 16 in 12-week-old female BALB/c mice fed either high soy protein (n = 10) or low soy protein (n = 10) diet.
(L and M) Survival (L) and DNA mutation frequency (M) of yeast exposed to a 0.53, 13, or 23 concentration of a standard amino acid mix.
(N) PDS and STRE activity in yeast grown in media containing only Trp, Leu, and His compared to those grown in the presence of all amino acids.
(O) RAS2 deletion protects against oxidative stress-induced genomic instability measured as DNA mutation frequency (Canr) in wild-type (DBY746) and ras2D
mutants chronically exposed to 1 mM H2O2.
(P) A model for the effect of amino acids on aging and genomic instability in S. cerevisiae. Amino acids activate the Tor-Sch9 and Ras-cAMP-PKA pathway also
activated by glucose and promote age- and oxidative stress-dependent genomic instability in part via reduced activity of Gis1 and Msn2/4. In all graphs, data
points represent the mean of the biological replicates ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Cell Metabolism
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become malnourished and unable to absorb or process a suffi-
cient level of amino acids. To test this possibility in mice, we
fed young mice (18 weeks old) and old mice (24 months old)412 Cell Metabolism 19, 407–417, March 4, 2014 ª2014 Elsevier Inc.with isocaloric diets containing either 18% or 4% animal protein.
A very low protein diet was purposely selected to reveal any
sensitivity to protein restriction in an old organism. Whereas
old mice maintained on a high protein diet for 30 days gained
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A B Figure 4. Effect of Protein Intake on Body
Weight in Young and Old Mice
(A) Young (18-week-old; n = 10) and old (24-
month-old; n = 6) C57BL/6 mice fed a high (18%)
protein diet.
(B) Young (18-week-old; n = 10) and old (24-
month-old; n = 6) C57BL/6 mice fed a low (4%)
protein diet. Data points represent mean ± SEM.
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their weight by day 15 (Figures 4A and 4B), in agreement with the
effect of aging on turning the beneficial effects of protein restric-
tion on mortality into negative effects.
DISCUSSION
Here, using a major nationally representative study of nutrition in
the United States population, our results show that among those
ages 50 and above, the level of protein intake is associated with
increased risk of diabetes mortality, but not associated with dif-
ferences in all-cause, cancer, or CVDmortality. Nevertheless, we
found an age interaction for the association between protein
consumption and mortality, both overall and from cancer, with
subjects ages 50–65 years potentially experiencing benefits
from low protein intake, and subjects ages 66+ experiencing det-
riments. This may explain why previously the strong association
between protein intake, IGF-1, disease, and mortality has been
poorly understood and controversial (Saydah et al., 2007).
Furthermore, among 2,253 subjects, the risks of all-cause and
cancer mortality for those with high protein intake compared to
the low protein intake group were increased even further for
those who also had high levels of IGF-1. This is in agreement
with previous studies associating IGF-1 levels to various types
of cancer (Giovannucci et al., 2003; Guevara-Aguirre et al.,
2011; Pollak et al., 2004).
Notably, our results showed that the amount of proteins
derived from animal sources accounted for a significant propor-
tion of the association between overall protein intake and all-
cause and cancer mortality. These results are in agreement
with recent findings on the association between red meat con-
sumption and death from all-cause and cancer (Fung et al.,
2010; Pan et al., 2012). Previous studies in the U.S. have found
that a low carbohydrate diet is associated with an increase in
overall mortality and showed that when such a diet is from
animal-based products, the risk of overall as well as cancer
mortality is increased even further (Fung et al., 2010; Lagiou
et al., 2007). Our study indicates that high levels of animal pro-
teins, promoting increases in IGF-1 and possibly insulin, is one
of the major promoters of mortality for people age 50–65 in the
18 years following the survey assessing protein intake.
Our results from yeast andmicemay explain at least part of the
fundamental connection between protein intake, cancer, and
overall mortality by providing a link between amino acids, stress
resistance, DNA damage, and cancer incidence/progression. In
mice, the changes caused by reduced protein levels had an
effect potent enough to prevent the establishment of 10%–Ce30% of tumors, even when 20,000 tumor cells were already pre-
sent at a subcutaneous site. Furthermore, the progression of
both melanoma and breast cancer was strongly attenuated by
the low protein diet, indicating that low protein diets may have
applications in both cancer prevention and treatment, in agree-
ment with previous studies (Fontana et al., 2006, 2008; McCarty,
2011; Youngman, 1993).
Although protein intake is associated with increased mortality
for adults who were middle-aged at baseline, there was also
evidence that a low protein diet may be hazardous for older
adults. Both high and moderate protein intake in the elderly
were associated with reduced mortality compared to that in
the low protein group, suggesting that protein intake represent-
ing at least 10% of the calories consumed may be necessary af-
ter age 65 to reduce age-dependent weight loss and prevent an
excessive loss of IGF-1 and of other important factors. In fact,
previous studies have noted that an increased protein intake
and the resulting increase in IGF-1 may prove beneficial in older
adults (Heaney et al., 1999), and the switch from the protective
to the detrimental effect of the low protein diet coincides with a
time at which weight begins to decline. Based on previous longi-
tudinal studies, weight tends to increase up until age 50–60, at
which point it becomes stable before beginning to decline
steadily by an average of 0.5% per year for those over age 65
(Villareal et al., 2005; Wallace et al., 1995). We speculate that frail
subjects who have lost a significant percentage of their body
weight and have a low BMI may be more susceptible to protein
malnourishment. It is also possible that other factors such as
inflammation or genetic factors may contribute to the sensitivity
to protein restriction in elderly subjects, in agreement with our
mouse studies.
Although other studies have noted age-associated declines
of nutrient absorption in rodents related to changes in the pH
microclimate, impaired adaptive response in the aged gut,
and changes in the morphology of the intestine, there is still
no clear association between food absorption and mortality
(Chen et al., 1990; Woudstra and Thomson, 2002). In
humans, some studies have shown that dietary protein diges-
tion and absorption kinetics are not impaired in vivo in healthy,
elderly men. However, these studies have also reported in-
creased splanchnic extraction of amino acids, which might
result in decreased availability to peripheral tissues, and spec-
ulated that in the case of low protein intake or increased protein
requirement, the limited systemic availability of dietary amino
acids may contribute to decreased muscle protein synthesis
(Boirie et al., 1997; Koopman et al., 2009). Furthermore, in hu-
mans factors like poor dentition, medication, and psychosocialll Metabolism 19, 407–417, March 4, 2014 ª2014 Elsevier Inc. 413
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(Woudstra and Thomson, 2002).
IGF-1 has been previously shown to decrease at older ages
(Iranmanesh et al., 1991), possibly increasing the risk of frailty
(Lamberts et al., 1997) and mortality (Cappola et al., 2003).
Thus our findings may explain the controversy related to IGF-1
and mortality indicating that a minimum level of proteins and
possibly IGF-1 is important in the elderly, or that low circulating
IGF-1 reflects a state ofmalnourishment, frailty, and/or morbidity
(Maggio et al., 2007). In fact, inflammation and other disorders
are known to decrease IGF-1 levels, raising the possibility that
the low protein and low IGF-1 group may contain a significant
number of both malnourished and frail individuals having or in
the process of developing major diseases (Fontana et al., 2012).
There are some limitations to our study, which should be
acknowledged. First, the use of a single 24 hr dietary recall fol-
lowed by up to 18 years of mortality assessment has the poten-
tial of misclassifying dietary practice if the 24 hr period was not
representative of a participant’s normal day. However, 93% of
our sample reported that the 24 hr period represented a normal
day. We also include this variable as a control in our analysis.
Furthermore, the 24 hr dietary recall has been shown to be a valid
approach to identify the ‘‘usual diet’’ of subjects (Blanton et al.,
2006; Conway et al., 2004; Coulston and Boushey, 2008; Pren-
tice et al., 2011).While wemust admit that the lack of longitudinal
data on dietary consumption is a potential limitation of our study,
study of dietary consistency over six years among older people
revealed little change over time in dietary habits (Garry et al.,
1989). Another study looking at dietary habits over 20 years
showed that while energy intake decreased for protein, fat, and
carbohydrates as people aged, the decreaseswere equal across
the three types (Flynn et al., 1992).
Another limitation of our study is classification of respondents
into protein intake groups and small sample sizes, especially for
analyses involving diabetes mortality among persons without
diabetes at baseline, or participants in the IGF-1 subsample.
As a result, our hazard ratios and 95% confidence intervals
may be much larger than what would have been seen with a
larger sample size. Nevertheless, one would expect a small sam-
ple size to decrease statistical power and make it harder to
detect associations. Therefore, our ability to detect significance
indicates that the associations between protein andmortality are
robust. Furthermore, the lower limits of the 95% confidence in-
tervals from our mortality analyses were well above 1.0, signi-
fying that the increased risk is probably large. Finally, given these
limitations, our study was strengthened by its use of reliable
cause-specific mortality data, as well as its inclusion of a large
nationally representative sample, a feature often missing from
the previous literature.
Overall, our human and animal studies indicate that a low pro-
tein diet during middle age is likely to be beneficial for the pre-
vention of cancer, overall mortality, and possibly diabetes
through a process that may involve, at least in part, regulation
of circulating IGF-1 and possibly insulin levels. In agreement
with other epidemiological and animal studies (Estruch et al.,
2013; Linos and Willett, 2007; Michaud et al., 2001; Willett,
2006), our findings suggest that a diet in which plant-based nu-
trients represent the majority of the food intake is likely to maxi-
mize health benefits in all age groups. However, we propose that414 Cell Metabolism 19, 407–417, March 4, 2014 ª2014 Elsevier Inc.up to age 65 and possibly 70, depending on health status, the 0.7
to 0.8 g of proteins/kg of body weight/day reported by the Food
and Nutrition Board of the Institute of Medicine, currently viewed
as a minimum requirement, should be recommended instead of
the 1.0–1.3 g grams of proteins/kg of body weight/day
consumed by adults ages 19–70 (Fulgoni, 2008). We also pro-
pose that at older ages, it may be important to avoid low protein
intake and gradually adopt amoderate to high protein, preferably
mostly plant-based consumption to allow the maintenance of a
healthy weight and protection from frailty (Bartali et al., 2006;
Ferrucci et al., 2003; Kobayashi et al., 2013).
EXPERIMENTAL PROCEDURES
Nutrient Intake for Human Data
Nutrient intake data are based on reports of food and beverage intake during a
24 hr period. Data were collected via an automated, microcomputer-based
coding system, with information on over 80 nutrients. There are several advan-
tages to using this method for collecting dietary data. Given that the time
elapsing between consumption and recall is short, participants are typically
able to recall more information. Also, unlike many other reporting methods,
24 hr dietary recall relies on data collection after consumption, reducing the
potential for assessment to alter dietary behaviors (Coulston and Boushey,
2008). Furthermore, 24 hr recalls have been shown to be a stronger estimate
of total energy and protein consumption compared to the commonly used
food frequency questionnaires (Prentice et al., 2011), and have also been
shown to be a more valid measure of total energy and nutrient intake than
both the Block food-frequency questionnaire and the National Cancer Insti-
tute’s Diet History Questionnaire (Blanton et al., 2006). Finally, this approach
has been found to accurately assess energy, protein, fat, and carbohydrate
intake, regardless of body mass index (Conway et al., 2004).
Epidemiological Mortality Follow-Up
Mortality data were available from the National Death Index. Information for
113 potential underlying causes of death (UCOD-113) was used to determine
all-cause mortality, cardiovascular mortality, cancer mortality, and diabetes
mortality.
Statistical Analysis for Human Data
Cox proportional hazard models were used to estimate the association be-
tween intake of calories from protein on subsequent all-cause, CVD, cancer,
and diabetes mortality, with the latter three run using competing-risks struc-
tures. Next we tested the interaction between age and protein consumption
on the association with mortality. Based on these results, we categorized
subjects into two age groups (50–65 years and 66+ years), which were
used in the remainder of the analyses. age-stratified proportional hazard
models were used to estimate the association of percent calories from pro-
tein with mortality within the two age groups and examine whether the rela-
tionship was influenced by percent of calories from fat, percent of calories
from carbohydrates, or animal protein. Hazard models were re-estimated
for the IGF-1 subsample to determine whether including IGF-1 changed the
association between protein intake and mortality. Finally, proportional hazard
models were used to examine the interaction between protein and IGF-1 and
to calculate predicted hazard ratios for each protein group at various IGF-1
levels, to determine whether protein intake is differentially associated with
mortality depending on levels of IGF-1. All analyses were run using sample
weights, accounting for sampling design, and controlling for age, race/
ethnicity, education, sex, disease status, smoking, dietary changes,
attempted weight loss, and total calorie consumption.
Cancer Models in Mice
All animal experiments were performed according to procedures approved by
USC’s Institutional Animal Care and Use Committee. To establish a subcu-
taneous cancer mouse model, we injected 18-week-old male C57BL/6 mice
as well as 10-month-old GHRKO mice, age-matched littermate control mice
with B16 melanoma cells, and 12-week-old female BALB/c with 4T1 breast
Cell Metabolism
Protein Intake, IGF-1, and Mortalitycancer cells. Before injection, cells in log phase of growth were harvested and
suspended in serum-free, high-glucose Dulbecco’s modified Eagle’s medium
(DMEM) at 23 105 or 23 106 cells/ml, and 100 ml (23 104 cells per C57BL/6 or
BALB/c mouse; 2 3 105 cells per GHRKO mouse) was subsequently injected
subcutaneously in the lower back. All mice were shaved before subcutaneous
tumor injection. Tumor incidence was determined by palpation of the injected
area, and tumor size was measured using a digital Vernier caliper starting
10–15 days postimplantation. The experiments for C57BL/6 and BALB/c
mice ended at different time points based on USC IACUC-approved humane
endpoint criteria for tumor size and ulceration.
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